Univariate and multivariate Cox analyses showed that COPB2 may be a promising biomarker for glioma prognosis while a GSEA using TCGA data revealed that some inflammation‐ and immunity‐related pathways and other signaling pathways in cancer are differentially enriched in the COPB2 high expression phenotype. The gene discussed is COPB2; the disease is central nervous system cancer.